NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents.

Saved in:
Bibliographic Details
Title: NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents.
Authors: Laskin, J.1 jlaskin@bccancer.bc.ca, Liu, S.V.1,2, Tolba, K.3, Heining, C.4,5,6, Schlenk, R.F.7, Cheema, P.8, Cadranel, J.9, Jones, M.R.10, Drilon, A.11, Cseh, A.12, Gyorffy, S.13, Solca, F.14, Duruisseaux, M.15
Source: Annals of Oncology. Dec2020, Vol. 31 Issue 12, p1693-1703. 11p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first